Pharmena S.A.
PHR.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | 5.4% | -1.8% | 346.6% | – |
| Cost of Goods Sold | PLN 0 | PLN 1 | PLN 0 | PLN 0 |
| Gross Profit | PLN 0 | -PLN 1 | PLN 0 | PLN 0 |
| % Margin | 84.8% | -175.4% | 76.6% | 85.2% |
| R&D Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| G&A Expenses | PLN 1 | PLN 1 | PLN 1 | PLN 1 |
| SG&A Expenses | PLN 1 | PLN 1 | PLN 1 | PLN 1 |
| Sales & Mktg Exp. | PLN 0 | PLN 1 | PLN 0 | PLN 0 |
| Other Operating Expenses | PLN 0 | -PLN 1 | PLN 0 | -PLN 0 |
| Operating Expenses | PLN 1 | PLN 0 | PLN 1 | PLN 1 |
| Operating Income | -PLN 1 | -PLN 1 | -PLN 1 | -PLN 1 |
| % Margin | -193.4% | -226.9% | -169.5% | -828.4% |
| Other Income/Exp. Net | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Pre-Tax Income | -PLN 1 | -PLN 1 | -PLN 0 | -PLN 1 |
| Tax Expense | PLN 0 | PLN 0 | PLN 0 | -PLN 0 |
| Net Income | -PLN 1 | -PLN 1 | -PLN 0 | -PLN 0 |
| % Margin | -169.5% | -181.3% | -124.4% | -134.1% |
| EPS | 0 | -0.063 | -0.044 | -0.011 |
| % Growth | 100% | -43.1% | -314.2% | – |
| EPS Diluted | 0 | -0.07 | -0.044 | -0.011 |
| Weighted Avg Shares Out | 0 | 10 | 11 | 11 |
| Weighted Avg Shares Out Dil | 0 | 11 | 11 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Interest Expense | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Depreciation & Amortization | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| EBITDA | -PLN 1 | -PLN 1 | -PLN 0 | -PLN 1 |
| % Margin | -160% | -219.2% | -112.2% | -1,072.4% |